Report Detail

Request for Sample of this report

Chemical & Material Global Buparlisib Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

  • RnM4512667
    • |
  • 16 February, 2023
    • |
  • Global
    • |
  • 114 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Chemical & Material

Buparlisib is an orally bioavailable and selective pan-class I phosphatidylinositol-3 kinase (PI3K) inhibitor.
According to our (Global Info Research) latest study, the global Buparlisib market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Buparlisib market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Buparlisib market size and forecasts, in consumption value ($ Million), sales quantity (Kg), and average selling prices (K USD/Kg), 2018-2029
Global Buparlisib market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Kg), and average selling prices (K USD/Kg), 2018-2029
Global Buparlisib market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Kg), and average selling prices (K USD/Kg), 2018-2029
Global Buparlisib market shares of main players, shipments in revenue ($ Million), sales quantity (Kg), and ASP (K USD/Kg), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Buparlisib
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Buparlisib market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Selleck Chemicals, Abcam, BOC Sciences, Syd Labs and Santa Cruz Biotechnology, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Buparlisib market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%
Market segment by Application
Research
Medical
Major players covered
Selleck Chemicals
Abcam
BOC Sciences
Syd Labs
Santa Cruz Biotechnology
Cayman Chemical
BioVision
Shimadzu
Biosynth Carbosynth
Adooq Bioscience
Axon Medchem
TargetMol
Enzo Biochem
LGC
LKT Laboratories
InvivoChem
J&K Scientific
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Buparlisib product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Buparlisib, with price, sales, revenue and global market share of Buparlisib from 2018 to 2023.
Chapter 3, the Buparlisib competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Buparlisib breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Buparlisib market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Buparlisib.
Chapter 14 and 15, to describe Buparlisib sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Buparlisib
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Buparlisib Consumption Value by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Min Purity Less Than 98%
    • 1.3.3 Min Purity 98%-99%
    • 1.3.4 Min Purity More Than 99%
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Buparlisib Consumption Value by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Research
    • 1.4.3 Medical
  • 1.5 Global Buparlisib Market Size & Forecast
    • 1.5.1 Global Buparlisib Consumption Value (2018 & 2022 & 2029)
    • 1.5.2 Global Buparlisib Sales Quantity (2018-2029)
    • 1.5.3 Global Buparlisib Average Price (2018-2029)

2 Manufacturers Profiles

  • 2.1 Selleck Chemicals
    • 2.1.1 Selleck Chemicals Details
    • 2.1.2 Selleck Chemicals Major Business
    • 2.1.3 Selleck Chemicals Buparlisib Product and Services
    • 2.1.4 Selleck Chemicals Buparlisib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Selleck Chemicals Recent Developments/Updates
  • 2.2 Abcam
    • 2.2.1 Abcam Details
    • 2.2.2 Abcam Major Business
    • 2.2.3 Abcam Buparlisib Product and Services
    • 2.2.4 Abcam Buparlisib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Abcam Recent Developments/Updates
  • 2.3 BOC Sciences
    • 2.3.1 BOC Sciences Details
    • 2.3.2 BOC Sciences Major Business
    • 2.3.3 BOC Sciences Buparlisib Product and Services
    • 2.3.4 BOC Sciences Buparlisib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 BOC Sciences Recent Developments/Updates
  • 2.4 Syd Labs
    • 2.4.1 Syd Labs Details
    • 2.4.2 Syd Labs Major Business
    • 2.4.3 Syd Labs Buparlisib Product and Services
    • 2.4.4 Syd Labs Buparlisib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Syd Labs Recent Developments/Updates
  • 2.5 Santa Cruz Biotechnology
    • 2.5.1 Santa Cruz Biotechnology Details
    • 2.5.2 Santa Cruz Biotechnology Major Business
    • 2.5.3 Santa Cruz Biotechnology Buparlisib Product and Services
    • 2.5.4 Santa Cruz Biotechnology Buparlisib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Santa Cruz Biotechnology Recent Developments/Updates
  • 2.6 Cayman Chemical
    • 2.6.1 Cayman Chemical Details
    • 2.6.2 Cayman Chemical Major Business
    • 2.6.3 Cayman Chemical Buparlisib Product and Services
    • 2.6.4 Cayman Chemical Buparlisib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Cayman Chemical Recent Developments/Updates
  • 2.7 BioVision
    • 2.7.1 BioVision Details
    • 2.7.2 BioVision Major Business
    • 2.7.3 BioVision Buparlisib Product and Services
    • 2.7.4 BioVision Buparlisib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 BioVision Recent Developments/Updates
  • 2.8 Shimadzu
    • 2.8.1 Shimadzu Details
    • 2.8.2 Shimadzu Major Business
    • 2.8.3 Shimadzu Buparlisib Product and Services
    • 2.8.4 Shimadzu Buparlisib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Shimadzu Recent Developments/Updates
  • 2.9 Biosynth Carbosynth
    • 2.9.1 Biosynth Carbosynth Details
    • 2.9.2 Biosynth Carbosynth Major Business
    • 2.9.3 Biosynth Carbosynth Buparlisib Product and Services
    • 2.9.4 Biosynth Carbosynth Buparlisib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Biosynth Carbosynth Recent Developments/Updates
  • 2.10 Adooq Bioscience
    • 2.10.1 Adooq Bioscience Details
    • 2.10.2 Adooq Bioscience Major Business
    • 2.10.3 Adooq Bioscience Buparlisib Product and Services
    • 2.10.4 Adooq Bioscience Buparlisib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Adooq Bioscience Recent Developments/Updates
  • 2.11 Axon Medchem
    • 2.11.1 Axon Medchem Details
    • 2.11.2 Axon Medchem Major Business
    • 2.11.3 Axon Medchem Buparlisib Product and Services
    • 2.11.4 Axon Medchem Buparlisib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Axon Medchem Recent Developments/Updates
  • 2.12 TargetMol
    • 2.12.1 TargetMol Details
    • 2.12.2 TargetMol Major Business
    • 2.12.3 TargetMol Buparlisib Product and Services
    • 2.12.4 TargetMol Buparlisib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 TargetMol Recent Developments/Updates
  • 2.13 Enzo Biochem
    • 2.13.1 Enzo Biochem Details
    • 2.13.2 Enzo Biochem Major Business
    • 2.13.3 Enzo Biochem Buparlisib Product and Services
    • 2.13.4 Enzo Biochem Buparlisib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 Enzo Biochem Recent Developments/Updates
  • 2.14 LGC
    • 2.14.1 LGC Details
    • 2.14.2 LGC Major Business
    • 2.14.3 LGC Buparlisib Product and Services
    • 2.14.4 LGC Buparlisib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.14.5 LGC Recent Developments/Updates
  • 2.15 LKT Laboratories
    • 2.15.1 LKT Laboratories Details
    • 2.15.2 LKT Laboratories Major Business
    • 2.15.3 LKT Laboratories Buparlisib Product and Services
    • 2.15.4 LKT Laboratories Buparlisib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.15.5 LKT Laboratories Recent Developments/Updates
  • 2.16 InvivoChem
    • 2.16.1 InvivoChem Details
    • 2.16.2 InvivoChem Major Business
    • 2.16.3 InvivoChem Buparlisib Product and Services
    • 2.16.4 InvivoChem Buparlisib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.16.5 InvivoChem Recent Developments/Updates
  • 2.17 J&K Scientific
    • 2.17.1 J&K Scientific Details
    • 2.17.2 J&K Scientific Major Business
    • 2.17.3 J&K Scientific Buparlisib Product and Services
    • 2.17.4 J&K Scientific Buparlisib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.17.5 J&K Scientific Recent Developments/Updates

3 Competitive Environment: Buparlisib by Manufacturer

  • 3.1 Global Buparlisib Sales Quantity by Manufacturer (2018-2023)
  • 3.2 Global Buparlisib Revenue by Manufacturer (2018-2023)
  • 3.3 Global Buparlisib Average Price by Manufacturer (2018-2023)
  • 3.4 Market Share Analysis (2022)
    • 3.4.1 Producer Shipments of Buparlisib by Manufacturer Revenue ($MM) and Market Share (%): 2022
    • 3.4.2 Top 3 Buparlisib Manufacturer Market Share in 2022
    • 3.4.2 Top 6 Buparlisib Manufacturer Market Share in 2022
  • 3.5 Buparlisib Market: Overall Company Footprint Analysis
    • 3.5.1 Buparlisib Market: Region Footprint
    • 3.5.2 Buparlisib Market: Company Product Type Footprint
    • 3.5.3 Buparlisib Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Buparlisib Market Size by Region
    • 4.1.1 Global Buparlisib Sales Quantity by Region (2018-2029)
    • 4.1.2 Global Buparlisib Consumption Value by Region (2018-2029)
    • 4.1.3 Global Buparlisib Average Price by Region (2018-2029)
  • 4.2 North America Buparlisib Consumption Value (2018-2029)
  • 4.3 Europe Buparlisib Consumption Value (2018-2029)
  • 4.4 Asia-Pacific Buparlisib Consumption Value (2018-2029)
  • 4.5 South America Buparlisib Consumption Value (2018-2029)
  • 4.6 Middle East and Africa Buparlisib Consumption Value (2018-2029)

5 Market Segment by Type

  • 5.1 Global Buparlisib Sales Quantity by Type (2018-2029)
  • 5.2 Global Buparlisib Consumption Value by Type (2018-2029)
  • 5.3 Global Buparlisib Average Price by Type (2018-2029)

6 Market Segment by Application

  • 6.1 Global Buparlisib Sales Quantity by Application (2018-2029)
  • 6.2 Global Buparlisib Consumption Value by Application (2018-2029)
  • 6.3 Global Buparlisib Average Price by Application (2018-2029)

7 North America

  • 7.1 North America Buparlisib Sales Quantity by Type (2018-2029)
  • 7.2 North America Buparlisib Sales Quantity by Application (2018-2029)
  • 7.3 North America Buparlisib Market Size by Country
    • 7.3.1 North America Buparlisib Sales Quantity by Country (2018-2029)
    • 7.3.2 North America Buparlisib Consumption Value by Country (2018-2029)
    • 7.3.3 United States Market Size and Forecast (2018-2029)
    • 7.3.4 Canada Market Size and Forecast (2018-2029)
    • 7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

  • 8.1 Europe Buparlisib Sales Quantity by Type (2018-2029)
  • 8.2 Europe Buparlisib Sales Quantity by Application (2018-2029)
  • 8.3 Europe Buparlisib Market Size by Country
    • 8.3.1 Europe Buparlisib Sales Quantity by Country (2018-2029)
    • 8.3.2 Europe Buparlisib Consumption Value by Country (2018-2029)
    • 8.3.3 Germany Market Size and Forecast (2018-2029)
    • 8.3.4 France Market Size and Forecast (2018-2029)
    • 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
    • 8.3.6 Russia Market Size and Forecast (2018-2029)
    • 8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

  • 9.1 Asia-Pacific Buparlisib Sales Quantity by Type (2018-2029)
  • 9.2 Asia-Pacific Buparlisib Sales Quantity by Application (2018-2029)
  • 9.3 Asia-Pacific Buparlisib Market Size by Region
    • 9.3.1 Asia-Pacific Buparlisib Sales Quantity by Region (2018-2029)
    • 9.3.2 Asia-Pacific Buparlisib Consumption Value by Region (2018-2029)
    • 9.3.3 China Market Size and Forecast (2018-2029)
    • 9.3.4 Japan Market Size and Forecast (2018-2029)
    • 9.3.5 Korea Market Size and Forecast (2018-2029)
    • 9.3.6 India Market Size and Forecast (2018-2029)
    • 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
    • 9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

  • 10.1 South America Buparlisib Sales Quantity by Type (2018-2029)
  • 10.2 South America Buparlisib Sales Quantity by Application (2018-2029)
  • 10.3 South America Buparlisib Market Size by Country
    • 10.3.1 South America Buparlisib Sales Quantity by Country (2018-2029)
    • 10.3.2 South America Buparlisib Consumption Value by Country (2018-2029)
    • 10.3.3 Brazil Market Size and Forecast (2018-2029)
    • 10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

  • 11.1 Middle East & Africa Buparlisib Sales Quantity by Type (2018-2029)
  • 11.2 Middle East & Africa Buparlisib Sales Quantity by Application (2018-2029)
  • 11.3 Middle East & Africa Buparlisib Market Size by Country
    • 11.3.1 Middle East & Africa Buparlisib Sales Quantity by Country (2018-2029)
    • 11.3.2 Middle East & Africa Buparlisib Consumption Value by Country (2018-2029)
    • 11.3.3 Turkey Market Size and Forecast (2018-2029)
    • 11.3.4 Egypt Market Size and Forecast (2018-2029)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
    • 11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

  • 12.1 Buparlisib Market Drivers
  • 12.2 Buparlisib Market Restraints
  • 12.3 Buparlisib Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry
  • 12.5 Influence of COVID-19 and Russia-Ukraine War
    • 12.5.1 Influence of COVID-19
    • 12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Buparlisib and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Buparlisib
  • 13.3 Buparlisib Production Process
  • 13.4 Buparlisib Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Buparlisib Typical Distributors
  • 14.3 Buparlisib Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Buparlisib. Industry analysis & Market Report on Buparlisib is a syndicated market report, published as Global Buparlisib Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Buparlisib market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,742.24
    		4,113.36
    		5,484.48
    		3,250.32
    		4,875.48
    		6,500.64
    		547,682.40
    		821,523.60
    		1,095,364.80
    		290,823.60
    		436,235.40
    		581,647.20
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo